Grade Heterogeneity in Small Renal Masses: Potential Implications for Renal Mass Biopsy

Journal of Urology

Volumn 193, Issue 1, 2015, Pages 36-40

  Ball, Mark W ^a   Bezerra, Stephania M ^a   Gorin, Michael A ^a   Cowan, Morgan ^a   Pavlovich, Christian P ^a   Pierorazio, Phillip M ^a   Netto, George J ^a   Allaf, Mohamad E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

biopsy; carcinoma; neoplasm grading; renal cell; risk

Indexed keywords

ARTICLE; CANCER PATIENT; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY TUMOR; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RENAL MASS BIOPSY; TUMOR BIOPSY; TUMOR VOLUME; BIOPSY; CANCER GRADING; KIDNEY; KIDNEY CARCINOMA; PATHOLOGY;

BIOPSY; CARCINOMA, RENAL CELL; HUMANS; KIDNEY; KIDNEY NEOPLASMS; NEOPLASM GRADING;

EID: 84926099348     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.06.067     Document Type: Article

References (22)

1. 1 Nguyen, M.M., Gill, I.S., Ellison, L.M., The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J Urol, 176, 2006, 2397.
2. 2 Thompson, R.H., Kurta, J.M., Kaag, M., et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol, 181, 2009, 2033.
3. 3 Halverson, S.J., Kunju, L.P., Bhalla, R., et al. Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. J Urol, 189, 2013, 441.
4. 4 Volpe, A., Finelli, A., Gill, I.S., et al. Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol, 62, 2012, 491.
5. 5 Lebret, T., Poulain, J.E., Molinie, V., et al. Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol, 178, 2007, 1184.
6. 6 Leveridge, M.J., Finelli, A., Kachura, J.R., et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol, 60, 2011, 578.
7. 7 Millet, I., Curros, F., Serre, I., et al. Can renal biopsy accurately predict histological subtype and Fuhrman grade of renal cell carcinoma?. J Urol, 188, 2012, 1690.
8. 8 Neuzillet, Y., Lechevallier, E., Andre, M., et al. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol, 171, 2004, 1802.
9. 9 Schmidbauer, J., Remzi, M., Memarsadeghi, M., et al. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur Urol, 53, 2008, 1003.
10. 10 Volpe, A., Kachura, J.R., Geddie, W.R., et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol, 178, 2007, 379.
11. 11 Fuhrman, S.A., Lasky, L.C., Limas, C., Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol, 6, 1982, 655.
12. 12 Leibovich, B.C., Blute, M.L., Cheville, J.C., et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer, 97, 2003, 1663.
13. 13 Zisman, A., Pantuck, A.J., Dorey, F., et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol, 19, 2001, 1649.
14. 14 Frank, I., Blute, M.L., Cheville, J.C., et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol, 168, 2002, 2395.
15. 15 Higgins, J.P., McKenney, J.K., Brooks, J.D., et al. Recommendations for the reporting of surgically resected specimens of renal cell carcinoma: the Association of Directors of Anatomic and Surgical Pathology. Hum Pathol, 40, 2009, 456.
16. 16 Trpkov, K., Grignon, D.J., Bonsib, S.M., et al. Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations. Am J Surg Pathol, 37, 2013, 1505.
17. 17 Delahunt, B., Cheville, J.C., Martignoni, G., et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol, 37, 2013, 1490.
18. 18 Sun, M., Lughezzani, G., Jeldres, C., et al. A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Eur Urol, 56, 2009, 775.
19. 19 Moch, H., Schraml, P., Bubendorf, L., et al. Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization. Cancer Res, 58, 1998, 2304.
20. 20 Gerlinger, M., Rowan, A.J., Horswell, S., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med, 366, 2012, 883.
21. 21 Gerlinger, M., Horswell, S., Larkin, J., et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet, 46, 2014, 225.
22. 22 Snyder, M.E., Bach, A., Kattan, M.W., et al. Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol, 176, 2006, 2391.